Table 4.
Covariate | HR (95% CI) | P value |
---|---|---|
Time to first treatment | ||
15-60 d | Referent | |
0-14 d | 1.57 (1.20-2.06) | <.001 |
Sex | ||
Female | Referent | |
Male | 1.60 (1.15-2.23) | .005 |
Ann Arbor stage | ||
1-3 | Referent | |
4 | 1.02 (0.56-1.87) | .94 |
BM involvement | ||
No | Referent | |
Yes | 1.25 (0.71-2.21) | .44 |
B symptoms | ||
No | Referent | |
Yes | 1.13 (0.85-1.51) | .38 |
MIPI | ||
<5.7 | Referent | |
≥5.7 <6.2 | 1.28 (0.92-1.79) | .14 |
≥6.2 | 2.50 (1.81-3.46) | <.001 |
Intensive induction therapy | ||
No | Referent | |
Yes | 0.77 (0.59-1.01) | .06 |
Boldface value signifies statistically significant value.